scholarly journals P17.06: Comparing fetal frontonasal angle in the 18–20 week scan in pregnant women with prosthetic heart valves using low‐dose warfarin with a control group

2019 ◽  
Vol 54 (S1) ◽  
pp. 211-211
Author(s):  
S. Piri ◽  
L. Nezamabadi Farahani ◽  
N. Samiei
Keyword(s):  
Pregnant Women ◽  
Heart Valves ◽  
Low Dose ◽  
Control Group ◽  
Prosthetic Heart Valves ◽  
Dose Warfarin

scholarly journals Evaluation of the Antithrombotic Properties of Suloctidil in Patients with Substitute Heart Valves

1977 ◽  
Author(s):  
M. Moriau ◽  
A. Ferrant ◽  
C. Col-De Beys ◽  
A. Hurlet ◽  
C. Chalant ◽  
...  
Keyword(s):  
Platelet Count ◽  
Survival Time ◽  
Heart Valves ◽  
Treated Group ◽  
Control Group ◽  
Prosthetic Heart Valves ◽  
Biological Parameters ◽  
Platelet Adhesiveness ◽  
Thromboembolic Complications ◽  
Coagulation Parameters

Isotopic platelet survival time (PST), platelet count, adhesiveness, aggregation, PF4 release and coagulation parameters were examined in 23 patients with prosthetic heart valves (6 mitral, 10 aortic and 7 mitroaortic Starr Edwards or Bjork valves) treated with or without suloctidil.The patients were distributed in 2 comparative groups : the treated group with 11 patients with VKA (nicoumalone) and suloctidil (600 mg/day) and the control group with 12 patients with VKA alone. The biological parameters were performed before (the 10th postop. day) and 6 weeks after treatment with or without suloctidil.Before treatment were : PST shortened, platelet adhesiveness and aggregation normal and PF4 release, factors I, VIII-C, VIII-R-Ag increased in both groups.After treatment, PST returned to normal in the treated group, but remained unchanged or was more decreased in the control group. Platelet adhesiveness and aggregation were unchanged in both groups. PF4 release was reduced in the treated group and unchanged in the control group. Platelet count, factors I, VIII-C, VIII-R-Ag returned to the preoperative values in both groups.Two severe thromboembolic complications appeared in the control group, none in the treated group.

Efficacy of Low-Dose, Subcutaneously Administered Heparin in Treatment of Pregnant Women with Artificial Heart Valves

1984 ◽  
Vol 39 (7) ◽  
pp. 435-436
Author(s):  
REBECCA Y. C. WANG ◽  
PUI KEE LEE ◽  
JOSEPH S. F. CHOW ◽  
WALTER W. C. CHEN
Keyword(s):  
Pregnant Women ◽  
Artificial Heart ◽  
Heart Valves ◽  
Low Dose ◽  
Artificial Heart Valves
Sign in / Sign up

Export Citation Format

Share Document